2025 HIV Treatment and Prevention Agents Hospitals 
Pharmacy Times
JULY 16, 2025
Tarlatamab established a new standard for relapsed SCLC, with improved survival and easier administration, enhancing treatment accessibility. NALIRIFOX regimen showed improved overall survival in pancreatic cancer, underscoring the importance of dose optimization and toxicity management.
Pharmacy Times
JULY 25, 2025
Because of their ability to cover a wide array of bacteria, low adverse effect profile, and oral availability, cephalosporins are commonly used in the treatment of outpatient infections. Both agents have high bioavailability, achieve high urinary concentrations, are available as suspensions, and can be used in infants.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 24, 2025
Pharmacists are positioned to personalize HFpEF care through monitoring, patient-centered strategies, and shared decision-making, enhancing treatment adherence and outcomes. Finerenone, a nonsteroidal MRA, shows promise in reducing HF events and atrial fibrillation, offering potential benefits over steroidal MRAs like spironolactone.
Pharmacy Times
JULY 18, 2025
Image credit: OM | stock.adobe.com Why Proper Disposal Matters Disposing of medications appropriately helps prevent environmental contamination of water and soil. In April 2025, it had 4590 collection sites across the country and collected 310 tons of medications, bringing its all-time total to 9910 tons.
Pharmacy Times
AUGUST 8, 2025
GLP-1 receptor agonists should be considered as second-line agents for older adults with DKD, but potential gastrointestinal side effects must be monitored. SHOW MORE Pharmacists should consider GLP-1 receptor agonists as second-line agents in older adults with DKD when additional glycemic control is needed.
Pharmacy Times
AUGUST 2, 2025
The guidance is updated every 5 years, with the most recent update published in May 2025. These technologies prevent the risk of both hypo- and hyperglycemic episodes, facilitating safer fasting. Nieto, BS, PharmD Candidate Amy C.
Pharmacy Times
AUGUST 8, 2025
SHOW MORE Intranasal insulin shows promise in targeting memory regions of the brain, offering new hope for Alzheimer disease treatment in older adults. Insulin absorption varies between cognitively normal individuals and those with mild cognitive impairment, with higher uptake in the former.
Expert insights. Personalized for you.
Let's personalize your content